000			02125cam a2200337 a 4500
003			EG-GiCUC
005			20250223032253.0
008			190502s2018 ua dh f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.11.14.M.Sc.2018.Ma.O
100	0		_aMahmoud Ibrahim Ali
245	1	0	_aOutcome of mastectomy following Neo-adjvant chemotherapy for locally advanced breast cancer / _cMahmoud Ibrahim Ali ; Supervised Hafez Mohamed Hafez , Shrife Emad Eldin Yossef
246	1	5	_aدراسة النتائج المرجوة لأستئصال الثدى جراحيا بعد العلاج الكيماوى المساعد لمرضى سرطان الثدى المتقدم
260			_aCairo : _bMahmoud Ibrahim Ali , _c2018
300			_a117 P. : _bcharts , facsimiles ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of General Surgery
520			_aBackground: Neoadjuvant chemotherapy for breast cancer was originally used in locally advanced inoperable disease in order to achieve surgical resection. It was then extended to operable breast cancer with a view to down staging tumours to facilitate breast-conserving surgery. Increasingly, it is being considered as a treatment for earlier-stage disease. Methods: A retrospective study, discussing outcome of surgical intervention in breast cancer following neoadjuvant chemotherapy. It was conducted on 35 patients randomly selected from the files of surgical oncology department, in Luxor International Hospital over the last five years. Results: Conclusion: The neoadjuvant therapy is justified in patients with locally advanced breast cancer as they have bigger chance for breast preserving surgery
530			_aIssued also as CD
653		4	_aBreast cancer
653		4	_aBreast neoplasm
653		4	_aMRI
700	0		_aHafez Mohamed Hafez , _eSupervisor
700	0		_aShrife Emad Eldin Yossef , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aSamia _eCataloger
942			_2ddc _cTH
999			_c71735 _d71735